SCHEMBL26548858

SCHEMBL26548858

FC(F)(F)c1ccc(-c2ccc3ccc(-c4ccc(-c5cc(C(F)(F)F)cc(C(F)(F)F)c5)nc4)cc3c2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 4/20 0.47
IDO1 P14902 1/20 0.42
TDO2 P48775 1/20 0.42
MAOB P27338 1/20 0.42
TDP1 Q9NUW8 1/20 0.40
KIF11 P52732 3/20 0.40
NPBWR1 P48145 1/20 0.38
ALOX5AP P20292 4/20 0.37
FEN1 P39748 4/20 0.37
CA12 O43570 1/20 0.37
CA9 Q16790 1/20 0.37
TEK Q02763 1/20 0.37
HSD17B1 P14061 1/20 0.36
HSD17B2 P37059 1/20 0.36
RXRA P19793 1/20 0.36
RXRB P28702 1/20 0.36
RXRG P48443 1/20 0.36
CCNT1 O60563 1/20 0.36
CCNA2 P20248 1/20 0.36
CDK2 P24941 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26548847 0.94 TDO2 (0.45) KDM1AIDO1TDO2MAOBTDP1
SCHEMBL26548862 0.94 KDM1A (0.49) KDM1AIDO1TDO2MAOBTDP1
SCHEMBL26548844 0.92 KDM1A (0.48) KDM1AIDO1TDO2MAOBKIF11
SCHEMBL26548856 0.92 TDP1 (0.47) KDM1AIDO1TDO2TDP1TEK
SCHEMBL26567882 0.91 KDM1A (0.40) KDM1AIDO1TDO2MAOBTDP1
SCHEMBL26548363 0.90 IDO1 (0.46) KDM1AIDO1TDO2MAOBTDP1
SCHEMBL26548860 0.89 KDM1A (0.43) KDM1AIDO1TDO2MAOBTDP1
SCHEMBL26548354 0.88 KDM1A (0.49) KDM1AIDO1TDO2MAOBKIF11
SCHEMBL26548721 0.87 S1PR1 (0.44) KDM1AIDO1TDO2MAOBTDP1
SCHEMBL26548689 0.87 KIF11 (0.43) KDM1AIDO1TDO2MAOBKIF11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230337527-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME LAPTO CO., LTD. (KR) 2023-10-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230337527-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME AOC1, ODC1, PIEZO1 KDM1A 114/4885IDO1 2053/4885TDO2 1074/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.